المؤلفون: Merola JF; Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA., Landewé R; Amsterdam Rheumatology and Clinical Immunology Center, Amsterdam, Netherlands; Zuyderland MC, Heerlen, Netherlands., McInnes IB; College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. Electronic address: iain.mcinnes@glasgow.ac.uk., Mease PJ; Swedish Medical Center and Providence St Joseph Health and University of Washington, Seattle, WA, USA., Ritchlin CT; Department of Medicine, University of Rochester, Rochester, NY, USA., Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Asahina A; Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan., Behrens F; Division of Rheumatology, University Hospital and Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Goethe University, Frankfurt am Main, Germany., Gladman DD; Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, University of Toronto, ON, Canada., Gossec L; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France; Rheumatology Department, AP-HP, Pitié-Salpêtrière Hospital, Paris, France., Gottlieb AB; Department of Dermatology, The Icahn School of Medicine at Mt Sinai, New York, NY, USA., Thaçi D; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany., Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, UK., Ink B; UCB Pharma, Slough, UK., Assudani D; UCB Pharma, Slough, UK., Bajracharya R; UCB Pharma, Slough, UK., Shende V; UCB Pharma, Slough, UK., Coarse J; UCB Pharma, Morrisville, NC, USA., Coates LC; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Diseases University of Oxford, Oxford, UK; Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, Oxford, UK.

المصدر: Lancet (London, England) [Lancet] 2023 Jan 07; Vol. 401 (10370), pp. 38-48. Date of Electronic Publication: 2022 Dec 06.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal*/adverse effects , Antibodies, Monoclonal*/therapeutic use , Arthritis, Psoriatic*/drug therapy , Tumor Necrosis Factor-alpha*/antagonists & inhibitors, Adult ; Humans ; Double-Blind Method ; Immunologic Factors/therapeutic use ; Interleukin-17 ; Severity of Illness Index ; Treatment Outcome

المؤلفون: Ogdie A; From the University of Pennsylvania, Philadelphia, Pennsylvania; Corrona Research Foundation; New York University Hospital for Joint Diseases, New York, New York; University of Alabama at Birmingham, Birmingham, Alabama; University of Massachusetts, Worcester; Brigham and Women's Hospital, Boston, Massachusetts; University of California San Diego, San Diego, California; Albany Medical College, Albany, New York; Swedish Medical Center; University of Washington, Seattle, Washington, USA. alexis.ogdie@uphs.upenn.edu.; A. Ogdie, MD, MSCE, University of Pennsylvania; J.L. Palmer, PhD, Corrona Research Foundation; J. Greenberg, MD, New York University Hospital for Joint Diseases; J.R. Curtis, MD, MS, MPH, University of Alabama at Birmingham; L.R. Harrold, MD, MPH, Corrona Research Foundation; D.H. Solomon, MD, MPH, Brigham and Women's Hospital; A. Kavanaugh, MD, University of California at San Diego; J.M. Kremer, MD, Corrona Research Foundation, and Albany Medical College; P.J. Mease, MD, Swedish Medical Center, and University of Washington. alexis.ogdie@uphs.upenn.edu., Palmer JL; From the University of Pennsylvania, Philadelphia, Pennsylvania; Corrona Research Foundation; New York University Hospital for Joint Diseases, New York, New York; University of Alabama at Birmingham, Birmingham, Alabama; University of Massachusetts, Worcester; Brigham and Women's Hospital, Boston, Massachusetts; University of California San Diego, San Diego, California; Albany Medical College, Albany, New York; Swedish Medical Center; University of Washington, Seattle, Washington, USA.; A. Ogdie, MD, MSCE, University of Pennsylvania; J.L. Palmer, PhD, Corrona Research Foundation; J. Greenberg, MD, New York University Hospital for Joint Diseases; J.R. Curtis, MD, MS, MPH, University of Alabama at Birmingham; L.R. Harrold, MD, MPH, Corrona Research Foundation; D.H. Solomon, MD, MPH, Brigham and Women's Hospital; A. Kavanaugh, MD, University of California at San Diego; J.M. Kremer, MD, Corrona Research Foundation, and Albany Medical College; P.J. Mease, MD, Swedish Medical Center, and University of Washington., Greenberg J; From the University of Pennsylvania, Philadelphia, Pennsylvania; Corrona Research Foundation; New York University Hospital for Joint Diseases, New York, New York; University of Alabama at Birmingham, Birmingham, Alabama; University of Massachusetts, Worcester; Brigham and Women's Hospital, Boston, Massachusetts; University of California San Diego, San Diego, California; Albany Medical College, Albany, New York; Swedish Medical Center; University of Washington, Seattle, Washington, USA.; A. Ogdie, MD, MSCE, University of Pennsylvania; J.L. Palmer, PhD, Corrona Research Foundation; J. Greenberg, MD, New York University Hospital for Joint Diseases; J.R. Curtis, MD, MS, MPH, University of Alabama at Birmingham; L.R. Harrold, MD, MPH, Corrona Research Foundation; D.H. Solomon, MD, MPH, Brigham and Women's Hospital; A. Kavanaugh, MD, University of California at San Diego; J.M. Kremer, MD, Corrona Research Foundation, and Albany Medical College; P.J. Mease, MD, Swedish Medical Center, and University of Washington., Curtis JR; From the University of Pennsylvania, Philadelphia, Pennsylvania; Corrona Research Foundation; New York University Hospital for Joint Diseases, New York, New York; University of Alabama at Birmingham, Birmingham, Alabama; University of Massachusetts, Worcester; Brigham and Women's Hospital, Boston, Massachusetts; University of California San Diego, San Diego, California; Albany Medical College, Albany, New York; Swedish Medical Center; University of Washington, Seattle, Washington, USA.; A. Ogdie, MD, MSCE, University of Pennsylvania; J.L. Palmer, PhD, Corrona Research Foundation; J. Greenberg, MD, New York University Hospital for Joint Diseases; J.R. Curtis, MD, MS, MPH, University of Alabama at Birmingham; L.R. Harrold, MD, MPH, Corrona Research Foundation; D.H. Solomon, MD, MPH, Brigham and Women's Hospital; A. Kavanaugh, MD, University of California at San Diego; J.M. Kremer, MD, Corrona Research Foundation, and Albany Medical College; P.J. Mease, MD, Swedish Medical Center, and University of Washington., Harrold LR; From the University of Pennsylvania, Philadelphia, Pennsylvania; Corrona Research Foundation; New York University Hospital for Joint Diseases, New York, New York; University of Alabama at Birmingham, Birmingham, Alabama; University of Massachusetts, Worcester; Brigham and Women's Hospital, Boston, Massachusetts; University of California San Diego, San Diego, California; Albany Medical College, Albany, New York; Swedish Medical Center; University of Washington, Seattle, Washington, USA.; A. Ogdie, MD, MSCE, University of Pennsylvania; J.L. Palmer, PhD, Corrona Research Foundation; J. Greenberg, MD, New York University Hospital for Joint Diseases; J.R. Curtis, MD, MS, MPH, University of Alabama at Birmingham; L.R. Harrold, MD, MPH, Corrona Research Foundation; D.H. Solomon, MD, MPH, Brigham and Women's Hospital; A. Kavanaugh, MD, University of California at San Diego; J.M. Kremer, MD, Corrona Research Foundation, and Albany Medical College; P.J. Mease, MD, Swedish Medical Center, and University of Washington., Solomon DH; From the University of Pennsylvania, Philadelphia, Pennsylvania; Corrona Research Foundation; New York University Hospital for Joint Diseases, New York, New York; University of Alabama at Birmingham, Birmingham, Alabama; University of Massachusetts, Worcester; Brigham and Women's Hospital, Boston, Massachusetts; University of California San Diego, San Diego, California; Albany Medical College, Albany, New York; Swedish Medical Center; University of Washington, Seattle, Washington, USA.; A. Ogdie, MD, MSCE, University of Pennsylvania; J.L. Palmer, PhD, Corrona Research Foundation; J. Greenberg, MD, New York University Hospital for Joint Diseases; J.R. Curtis, MD, MS, MPH, University of Alabama at Birmingham; L.R. Harrold, MD, MPH, Corrona Research Foundation; D.H. Solomon, MD, MPH, Brigham and Women's Hospital; A. Kavanaugh, MD, University of California at San Diego; J.M. Kremer, MD, Corrona Research Foundation, and Albany Medical College; P.J. Mease, MD, Swedish Medical Center, and University of Washington., Kavanaugh A; From the University of Pennsylvania, Philadelphia, Pennsylvania; Corrona Research Foundation; New York University Hospital for Joint Diseases, New York, New York; University of Alabama at Birmingham, Birmingham, Alabama; University of Massachusetts, Worcester; Brigham and Women's Hospital, Boston, Massachusetts; University of California San Diego, San Diego, California; Albany Medical College, Albany, New York; Swedish Medical Center; University of Washington, Seattle, Washington, USA.; A. Ogdie, MD, MSCE, University of Pennsylvania; J.L. Palmer, PhD, Corrona Research Foundation; J. Greenberg, MD, New York University Hospital for Joint Diseases; J.R. Curtis, MD, MS, MPH, University of Alabama at Birmingham; L.R. Harrold, MD, MPH, Corrona Research Foundation; D.H. Solomon, MD, MPH, Brigham and Women's Hospital; A. Kavanaugh, MD, University of California at San Diego; J.M. Kremer, MD, Corrona Research Foundation, and Albany Medical College; P.J. Mease, MD, Swedish Medical Center, and University of Washington., Kremer JM; From the University of Pennsylvania, Philadelphia, Pennsylvania; Corrona Research Foundation; New York University Hospital for Joint Diseases, New York, New York; University of Alabama at Birmingham, Birmingham, Alabama; University of Massachusetts, Worcester; Brigham and Women's Hospital, Boston, Massachusetts; University of California San Diego, San Diego, California; Albany Medical College, Albany, New York; Swedish Medical Center; University of Washington, Seattle, Washington, USA.; A. Ogdie, MD, MSCE, University of Pennsylvania; J.L. Palmer, PhD, Corrona Research Foundation; J. Greenberg, MD, New York University Hospital for Joint Diseases; J.R. Curtis, MD, MS, MPH, University of Alabama at Birmingham; L.R. Harrold, MD, MPH, Corrona Research Foundation; D.H. Solomon, MD, MPH, Brigham and Women's Hospital; A. Kavanaugh, MD, University of California at San Diego; J.M. Kremer, MD, Corrona Research Foundation, and Albany Medical College; P.J. Mease, MD, Swedish Medical Center, and University of Washington., Mease PJ; From the University of Pennsylvania, Philadelphia, Pennsylvania; Corrona Research Foundation; New York University Hospital for Joint Diseases, New York, New York; University of Alabama at Birmingham, Birmingham, Alabama; University of Massachusetts, Worcester; Brigham and Women's Hospital, Boston, Massachusetts; University of California San Diego, San Diego, California; Albany Medical College, Albany, New York; Swedish Medical Center; University of Washington, Seattle, Washington, USA.; A. Ogdie, MD, MSCE, University of Pennsylvania; J.L. Palmer, PhD, Corrona Research Foundation; J. Greenberg, MD, New York University Hospital for Joint Diseases; J.R. Curtis, MD, MS, MPH, University of Alabama at Birmingham; L.R. Harrold, MD, MPH, Corrona Research Foundation; D.H. Solomon, MD, MPH, Brigham and Women's Hospital; A. Kavanaugh, MD, University of California at San Diego; J.M. Kremer, MD, Corrona Research Foundation, and Albany Medical College; P.J. Mease, MD, Swedish Medical Center, and University of Washington.

المصدر: The Journal of rheumatology [J Rheumatol] 2019 May; Vol. 46 (5), pp. 475-482. Date of Electronic Publication: 2019 Jan 15.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0315-162X (Print) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Registries*, Arthritis, Psoriatic/*diagnosis , Arthritis, Psoriatic/*drug therapy , Range of Motion, Articular/*drug effects , Tumor Necrosis Factor Inhibitors/*administration & dosage , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Adult ; Cohort Studies ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Pain Measurement ; Quality of Life ; Retrospective Studies ; Severity of Illness Index ; Time Factors ; Treatment Outcome ; United States

المؤلفون: Genovese MC; Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, CA, USA., Weinblatt ME; Rheumatology, Brigham and Women's Hospital, Rheumatology, Boston, MA, USA., Mease PJ; Rheumatology and Internal Medicine, Swedish Medical Center and University of Washington, Seattle, WA, USA., Aelion JA; Arthritis Clinic, Jackson, USA.; Department of Medicine, University of Tennessee, Memphis, TN, USA., Peloso PM; Clinical Development, AbbVie Inc., North Chicago, IL, USA., Chen K; Data and Statistical Sciences, AbbVie Inc., North Chicago, IL, USA., Li Y; Data and Statistical Sciences, AbbVie Inc., North Chicago, IL, USA., Liu J; Medical Safety Evaluation Pharmacovigilance and Patient Safety, AbbVie Inc., North Chicago, IL, USA., Othman AA; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA., Khatri A; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA., Mansikka HT; Clinical Development, AbbVie Inc., North Chicago, IL, USA., Leszczynski P; Rheumatology and Rehabilitation, Poznan University of Medical Sciences, Poznan, Poland.

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2018 Nov 01; Vol. 57 (11), pp. 1972-1981.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

مواضيع طبية MeSH: Antirheumatic Agents/*therapeutic use , Arthritis, Psoriatic/*drug therapy , Arthritis, Rheumatoid/*drug therapy , Immunoglobulins/*therapeutic use , Interleukin-17/*antagonists & inhibitors , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Adult ; Aged ; Arthritis, Psoriatic/diagnosis ; Arthritis, Rheumatoid/diagnosis ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Male ; Methotrexate/therapeutic use ; Middle Aged ; Severity of Illness Index ; Treatment Outcome

المؤلفون: Mease PJ; Swedish Medical Center and University of Washington, Seattle., Genovese MC; Stanford University Medical Center, Palo Alto, California., Weinblatt ME; Brigham and Women's Hospital, Boston, Massachusetts., Peloso PM; AbbVie Inc., North Chicago, Illinois., Chen K; AbbVie Inc., North Chicago, Illinois., Othman AA; AbbVie Inc., North Chicago, Illinois., Li Y; AbbVie Inc., North Chicago, Illinois., Mansikka HT; AbbVie Inc., North Chicago, Illinois., Khatri A; AbbVie Inc., North Chicago, Illinois., Wishart N; AbbVie Inc., North Chicago, Illinois., Liu J; AbbVie Inc., North Chicago, Illinois.

المصدر: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2018 Nov; Vol. 70 (11), pp. 1778-1789.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Antirheumatic Agents/*therapeutic use , Arthritis, Psoriatic/*drug therapy , Immunoglobulins/*therapeutic use , Interleukin-17/*antagonists & inhibitors , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Adult ; Double-Blind Method ; Female ; Humans ; Male ; Methotrexate/therapeutic use ; Middle Aged ; Treatment Outcome

المؤلفون: Coates LC; Leeds Institute of Rheumatic and Musculoskeletal Medicine and University of Leeds, Leeds, UK., Kavanaugh A; University of California at San Diego., Mease PJ; Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington., Soriano ER; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Laura Acosta-Felquer M; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Armstrong AW; University of Southern California, Keck School of Medicine, Los Angeles., Bautista-Molano W; Hospital Militar Central and Universidad Militar Nueva Grenada, Bogotá, Colombia., Boehncke WH; Geneva University Hospital, Geneva, Switzerland., Campbell W; Toronto Western Hospital, Toronto, Ontario, Canada., Cauli A; University of Cagliari, Monserrato Campus, Cagliari, Italy., Espinoza LR; Louisiana State University Health Sciences Center, New Orleans., FitzGerald O; St. Vincent's University Hospital, The Conway Institute for Biomolecular Research, and University College Dublin, Dublin, Ireland., Gladman DD; University of Toronto and Toronto Western Research Institute, Toronto, Ontario, Canada., Gottlieb A; Tufts Medical Center, Boston, Massachusetts., Helliwell PS; Leeds Institute of Rheumatic and Musculoskeletal Medicine and University of Leeds, Leeds, UK, and Bradford Hospitals NHS Foundation Trust, Bradford, UK., Husni ME; Cleveland Clinic Foundation, Cleveland, Ohio., Love TJ; University of Iceland and Landspitali University Hospital, Reykjavik, Iceland., Lubrano E; University of Molise, Campobasso, Italy., McHugh N; Royal National Hospital for Rheumatic Diseases, Bath, UK., Nash P; University of Queensland, Brisbane, Queensland, Australia., Ogdie A; University of Pennsylvania, Philadelphia., Orbai AM; Johns Hopkins University School of Medicine, Baltimore, Maryland., Parkinson A; Chapel Allerton Hospital, Leeds, UK., O'Sullivan D; St. Vincent's University Hospital, Dublin, Ireland., Rosen CF; Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada., Schwartzman S; Hospital for Special Surgery, New York, New York., Siegel EL; Arthritis and Rheumatism Associates, Rockville, Maryland., Toloza S; Ministry of Health, San Fernando del Valle de Catamarca, Argentina., Tuong W; University of California, Davis., Ritchlin CT; University of Rochester Medical Center, Rochester, New York.

المصدر: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2016 May; Vol. 68 (5), pp. 1060-71. Date of Electronic Publication: 2016 Mar 23.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Physical Therapy Modalities*, Adrenal Cortex Hormones/*therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use , Antirheumatic Agents/*therapeutic use , Arthritis, Psoriatic/*therapy , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Administration, Oral ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Humans ; Injections, Intra-Articular ; Ustekinumab/therapeutic use

المؤلفون: Kristensen LE; From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark.L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital. Larserik_kristensen@yahoo.com., Lie E; From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark.L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital., Jacobsson LT; From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark.L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital., Christensen R; From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark.L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital., Mease PJ; From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark.L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital., Bliddal H; From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark.L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital., Geborek P; From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark.L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital.

المصدر: The Journal of rheumatology [J Rheumatol] 2016 Jan; Vol. 43 (1), pp. 81-7. Date of Electronic Publication: 2015 Dec 01.

نوع المنشور: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0315-162X (Print) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Arthritis, Psoriatic/*drug therapy , Drug Substitution/*methods , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Adalimumab/administration & dosage ; Adult ; Arthritis, Psoriatic/diagnosis ; Cohort Studies ; Etanercept/administration & dosage ; Feasibility Studies ; Female ; Follow-Up Studies ; Humans ; Infliximab/administration & dosage ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Middle Aged ; Prospective Studies ; Risk Assessment ; Severity of Illness Index ; Statistics, Nonparametric ; Sweden ; Treatment Outcome ; Tumor Necrosis Factor-alpha/administration & dosage

المؤلفون: Tak PP; Division of Clinical Immunology and Rheumatology, Academic Medical Centre and University of Amsterdam, Amsterdam, The Netherlands. p.p.tak@amc.uva.nl, Mease PJ, Genovese MC, Kremer J, Haraoui B, Tanaka Y, Bingham CO 3rd, Ashrafzadeh A, Travers H, Safa-Leathers S, Kumar S, Dummer W

المصدر: Arthritis and rheumatism [Arthritis Rheum] 2012 Feb; Vol. 64 (2), pp. 360-70.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370605 Publication Model: Print Cited Medium: Internet ISSN: 1529-0131 (Electronic) Linking ISSN: 00043591 NLM ISO Abbreviation: Arthritis Rheum Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*therapeutic use , Antirheumatic Agents/*therapeutic use , Arthritis, Rheumatoid/*drug therapy , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Adult ; Aged ; Antibodies, Monoclonal, Humanized/adverse effects ; Antirheumatic Agents/adverse effects ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome

المؤلفون: Mease PJ; Seattle Rheumatology Associates, Seattle, WA 98104, USA. pmease@nwlink.com

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2011 Feb; Vol. 50 (2), pp. 261-70. Date of Electronic Publication: 2010 Sep 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

مواضيع طبية MeSH: Arthritis, Rheumatoid/*drug therapy , Immunoglobulin Fab Fragments/*adverse effects , Immunoglobulin Fab Fragments/*therapeutic use , Polyethylene Glycols/*adverse effects , Polyethylene Glycols/*therapeutic use , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Antibodies, Monoclonal, Humanized ; Antirheumatic Agents/therapeutic use ; Certolizumab Pegol ; Humans ; Immunoglobulin Fab Fragments/administration & dosage ; Methotrexate/administration & dosage ; Methotrexate/adverse effects ; Polyethylene Glycols/administration & dosage ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Tumor Necrosis Factor-alpha/adverse effects

المؤلفون: Gladman DD; Toronto Western Hospital, 399 Bathurst Street, 1E410B, Toronto, Ontario M5T 2S8, Canada. dafna.gladman@utoronto.ca, Tom BD, Mease PJ, Farewell VT

المصدر: The Journal of rheumatology [J Rheumatol] 2010 Sep; Vol. 37 (9), pp. 1892-7. Date of Electronic Publication: 2010 Jul 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0315-162X (Print) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Models, Statistical* , Randomized Controlled Trials as Topic*, Arthritis, Psoriatic/*drug therapy , Arthritis, Psoriatic/*immunology , Immunosuppressive Agents/*therapeutic use , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Arthritis, Psoriatic/pathology ; Arthritis, Psoriatic/physiopathology ; Clinical Trials, Phase III as Topic ; Etanercept ; Health Status ; Humans ; Immunoglobulin G/therapeutic use ; Placebos/therapeutic use ; Receptors, Tumor Necrosis Factor/therapeutic use ; Severity of Illness Index ; Surveys and Questionnaires ; Treatment Outcome

المؤلفون: Mease PJ; Swedish Medical Center, Division of Rheumatology Research, Seattle Rheumatology Associates, University of Washington, 1101 Madison Street, Suite 1000, Seattle, WA 98104, USA. pmease@nwlink.com

المصدر: Current rheumatology reports [Curr Rheumatol Rep] 2010 Aug; Vol. 12 (4), pp. 272-80.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 100888970 Publication Model: Print Cited Medium: Internet ISSN: 1534-6307 (Electronic) Linking ISSN: 15233774 NLM ISO Abbreviation: Curr Rheumatol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antirheumatic Agents/*therapeutic use , Arthritis, Psoriatic/*therapy , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Humans ; Severity of Illness Index ; Treatment Outcome